This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Geller, D. H. Articles by Miller, W. L. Search for Related Content PubMed PubMed Citation Articles by Geller, D. H. Articles by Miller, W. L.

P450c17 Mutations R347H and R358Q Selectively Disrupt 17,20-Lyase Activity by Disrupting Interactions with P450 Oxidoreductase and Cytochrome b₅

Department of Pediatrics (D.H.G., R.J.A., W.L.M.) Department of Internal Medicine (R.J.A.) and The Metabolic Research Unit (W.L.M.) University of California San Francisco, California 94143-0978

Cytochrome P450c17 catalyzes steroid 17-hydroxylase and 17,20-lyase activities and hence is a key enzyme in the production of human glucocorticoids and sex steroids. These two activities are catalyzed in a single substrate-binding site but are regulated independently in human physiology. We have recently shown that cytochrome b₅ facilitates 17,20-lyase activity by allosterically promoting the interaction of P450c17 with P450 oxidoreductase (OR) and that the human P450c17 mutations, R347H and R358Q, selectively destroy 17,20-lyase activity while sparing 17-hydroxylase activity. We transfected COS-1 cells with vectors for these P450c17 mutants and found that an excess of OR and b₅ restored a small amount of 17,20-lyase activity, suggesting the mutations interfere with electron donation. To determine whether these mutations selectively interfere with the interaction of P450c17 and its electron-donating system, we expressed each P450c17 mutant in yeast with or without OR, b₅, or both, and measured enzyme kinetics in yeast microsomes using pregnenolone and 17-hydroxypregnenolone as substrates. The apparent Michaelis-Menten (K_m) values for the R347H mutant with and without coexpressed OR were 0.2 and 0.6 µM, respectively, and for the R358Q mutant with and without OR they were 0.3 and 0.4 µM, respectively; these values did not differ significantly from the wild-type values of 0.4 and 0.8 µM with and without OR, respectively. Furthermore, coincubation with 17-hydroxypregnenolone showed a competitive mechanism for interference of catalysis. The similar kinetics and the competitive inhibition prove that the mutations did not affect the active site. Coexpression of the mutants with OR yielded insignificant 17,20-lyase activity, but addition of a 30:1 molar excess cytochrome b₅ to these microsomes restored partial 17,20-lyase activity, with the R358Q mutant achieving twice the activity of the R347H mutant. These data indicate that both mutations selectively interfere with 17,20-lyase activity by altering the interaction of P450c17 with OR, thus proving that the lyase activity was disrupted by interfering with electron transfer. Furthermore, the data offer the first evidence that R347 is a crucial component of the site at which b₅ interacts with the P450c17·OR complex to promote electron transfer.

This article has been cited by other articles:

				J C. Pattison, D. H Abbott, W. Saltzman, A. J Conley, and I. M Bird Plasticity of the zona reticularis in the adult marmoset adrenal cortex: voyages of discovery in the New World J. Endocrinol., December 1, 2009; 203(3): 313 - 326. [Abstract] [Full Text] [PDF]

				V. Dhir, N. Reisch, C. M. Bleicken, J. Lebl, C. Kamrath, H.-P. Schwarz, J. Grotzinger, W. G. Sippell, F. G. Riepe, W. Arlt, et al. Steroid 17{alpha}-Hydroxylase Deficiency: Functional Characterization of Four Mutations (A174E, V178D, R440C, L465P) in the CYP17A1 Gene J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3058 - 3064. [Abstract] [Full Text] [PDF]

				T. Sahakitrungruang, M. K. Tee, P. W. Speiser, and W. L. Miller Novel P450c17 Mutation H373D Causing Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3089 - 3092. [Abstract] [Full Text] [PDF]

				E. Hershkovitz, R. Parvari, S. A. Wudy, M. F. Hartmann, L. G. Gomes, N. Loewental, and W. L. Miller Homozygous Mutation G539R in the Gene for P450 Oxidoreductase in a Family Previously Diagnosed as Having 17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3584 - 3588. [Abstract] [Full Text] [PDF]

				M. K. Tee, Q. Dong, and W. L. Miller Pathways Leading to Phosphorylation of P450c17 and to the Posttranslational Regulation of Androgen Biosynthesis Endocrinology, May 1, 2008; 149(5): 2667 - 2677. [Abstract] [Full Text] [PDF]

				D. Tiosano, C. Knopf, I. Koren, N. Levanon, M. F Hartmann, Z. Hochberg, and S. A Wudy Metabolic evidence for impaired 17{alpha}-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity Eur. J. Endocrinol., March 1, 2008; 158(3): 385 - 392. [Abstract] [Full Text] [PDF]

				S. Rosa, C. Duff, M. Meyer, M. Lang-Muritano, G. Balercia, M. Boscaro, A. Kemal Topaloglu, R. Mioni, F. Fallo, L. Zuliani, et al. P450c17 Deficiency: Clinical and Molecular Characterization of Six Patients J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1000 - 1007. [Abstract] [Full Text] [PDF]

				S. H. Mellon, S. R. Bair, C. Depoix, J.-L. Vigne, N. B. Hecht, and P. B. Brake Translin Coactivates Steroidogenic Factor-1-Stimulated Transcription Mol. Endocrinol., January 1, 2007; 21(1): 89 - 105. [Abstract] [Full Text] [PDF]

				T. Robins, J. Carlsson, M. Sunnerhagen, A. Wedell, and B. Persson Molecular Model of Human CYP21 Based on Mammalian CYP2C5: Structural Features Correlate with Clinical Severity of Mutations Causing Congenital Adrenal Hyperplasia Mol. Endocrinol., November 1, 2006; 20(11): 2946 - 2964. [Abstract] [Full Text] [PDF]

				M. Janner, A. V Pandey, P. E Mullis, and C. E Fluck Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein. Eur. J. Endocrinol., July 1, 2006; 155(1): 143 - 151. [Abstract] [Full Text] [PDF]

				M K Akhtar, S L Kelly, and M A Kaderbhai Cytochrome b5 modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis J. Endocrinol., November 1, 2005; 187(2): 267 - 274. [Abstract] [Full Text] [PDF]

				N. Huang, A. Dardis, and W. L. Miller Regulation of Cytochrome b5 Gene Transcription by Sp3, GATA-6, and Steroidogenic Factor 1 in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2005; 19(8): 2020 - 2034. [Abstract] [Full Text] [PDF]

				W. L. Miller Minireview: Regulation of Steroidogenesis by Electron Transfer Endocrinology, June 1, 2005; 146(6): 2544 - 2550. [Abstract] [Full Text] [PDF]

				M. Taniyama, M. Tanabe, H. Saito, Y. Ban, H. Nawata, and T. Yanase Subtle 17{alpha}-Hydroxylase/17,20-Lyase Deficiency with Homozygous Y201N Mutation in an Infertile Woman J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2508 - 2511. [Abstract] [Full Text] [PDF]

				A. V. Pandey and W. L. Miller Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17 J. Biol. Chem., April 8, 2005; 280(14): 13265 - 13271. [Abstract] [Full Text] [PDF]

				W.-H. Yang and S. R Hammes Xenopus laevis CYP17 Regulates Androgen Biosynthesis Independent of the Cofactor Cytochrome b5 J. Biol. Chem., March 18, 2005; 280(11): 10196 - 10201. [Abstract] [Full Text] [PDF]

				J. R. Wood, V. L. Nelson-Degrave, E. Jansen, J. M. McAllister, S. Mosselman, and J. F. Strauss III Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects Physiol Genomics, February 10, 2005; 20(3): 233 - 243. [Abstract] [Full Text] [PDF]

				S. Dharia, A. Slane, M. Jian, M. Conner, A. J. Conley, and C. R. Parker Jr Colocalization of P450c17 and Cytochrome b5 in Androgen-Synthesizing Tissues of the Human Biol Reprod, July 1, 2004; 71(1): 83 - 88. [Abstract] [Full Text] [PDF]

				M. J. ten Kate-Booij, C. Cobbaert, J. W. Koper, and F. H. de Jong Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46,XY sister: Case report Hum. Reprod., February 1, 2004; 19(2): 456 - 459. [Abstract] [Full Text] [PDF]

				M. Costa-Santos, C. E. Kater, and R. J. Auchus Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 49 - 60. [Abstract] [Full Text] [PDF]

				D. P. Sherbet, D. Tiosano, K. M. Kwist, Z. Hochberg, and R. J. Auchus CYP17 Mutation E305G Causes Isolated 17,20-Lyase Deficiency by Selectively Altering Substrate Binding J. Biol. Chem., December 5, 2003; 278(49): 48563 - 48569. [Abstract] [Full Text] [PDF]

				J. R. Wood, V. L. Nelson, C. Ho, E. Jansen, C. Y. Wang, M. Urbanek, J. M. McAllister, S. Mosselman, and J. F. Strauss III The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis J. Biol. Chem., July 11, 2003; 278(29): 26380 - 26390. [Abstract] [Full Text] [PDF]

				A. V. Pandey, S. H. Mellon, and W. L. Miller Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17 J. Biol. Chem., January 24, 2003; 278(5): 2837 - 2844. [Abstract] [Full Text] [PDF]

				E. L. T. van den Akker, J. W. Koper, A. L. M. Boehmer, A. P. N. Themmen, M. Verhoef-Post, M. A. Timmerman, B. J. Otten, S. L. S. Drop, and F. H. De Jong Differential Inhibition of 17{alpha}-Hydroxylase and 17,20-Lyase Activities by Three Novel Missense CYP17 Mutations Identified in Patients with P450c17 Deficiency J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5714 - 5721. [Abstract] [Full Text] [PDF]

				W. Arlt, J. W. M. Martens, M. Song, J. T. Wang, R. J. Auchus, and W. L. Miller Molecular Evolution of Adrenarche: Structural and Functional Analysis of P450c17 from Four Primate Species Endocrinology, December 1, 2002; 143(12): 4665 - 4672. [Abstract] [Full Text] [PDF]

				M. K. Gupta, D. H. Geller, and R. J. Auchus Pitfalls in Characterizing P450c17 Mutations Associated with Isolated 17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4416 - 4423. [Abstract] [Full Text] [PDF]

				C. J. Lin, J. W. M. Martens, and W. L. Miller NF-1C, Sp1, and Sp3 Are Essential for Transcription of the Human Gene for P450c17 (Steroid 17{alpha}-hydroxylase/17,20 lyase) in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2001; 15(8): 1277 - 1293. [Abstract] [Full Text] [PDF]

				R. Azziz, L. M. Fox, H. A. Zacur, C. R. Parker Jr., and L. R. Boots Adrenocortical Secretion of Dehydroepiandrosterone in Healthy Women: Highly Variable Response to Adrenocorticotropin J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2513 - 2517. [Abstract] [Full Text] [PDF]

				P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text]

				A. Biason-Lauber, M. Zachmann, and E. J. Schoenle Effect of Leptin on CYP17 Enzymatic Activities in Human Adrenal Cells: New Insight in the Onset of Adrenarche Endocrinology, April 1, 2000; 141(4): 1446 - 1454. [Abstract] [Full Text] [PDF]

				A. Biason-Lauber, B. Kempken, E. Werder, M. G. Forest, S. Einaudi, M. B. Ranke, N. Matsuo, V. Brunelli, E. J. Schönle, and M. Zachmann 17{alpha}-Hydroxylase/17,20-Lyase Deficiency as a Model to Study Enzymatic Activity Regulation: Role of Phosphorylation J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1226 - 1231. [Abstract] [Full Text]

				W. L. Miller and R. J. Auchus Role of Cytochrome b5 in the 17,20-Lyase Activity of P450c17 J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1346 - 1346. [Full Text]

				R. J. Auchus and W. L. Miller Molecular Modeling of Human P450c17 (17{alpha}-Hydroxylase/ 17,20-Lyase): Insights into Reaction Mechanisms and Effects of Mutations Mol. Endocrinol., July 1, 1999; 13(7): 1169 - 1182. [Abstract] [Full Text]

				T. C. Lee, W. L. Miller, and R. J. Auchus Medroxyprogesterone Acetate and Dexamethasone Are Competitive Inhibitors of Different Human Steroidogenic Enzymes J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2104 - 2110. [Abstract] [Full Text]

				W. Arlt, R. J. Auchus, and W. L. Miller Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3beta -Hydroxysteroid Dehydrogenase J. Biol. Chem., May 11, 2001; 276(20): 16767 - 16771. [Abstract] [Full Text] [PDF]